Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).

Date Range:

	ANCHIANO THERAP/S	Acerus Pharmaceuticals	Acerus Pharmaceuticals	Amarillo Biosciences	Melinta Therapeutics
Symbol	NASDAQ:ANCN	OTCMKTS:TRLPF	OTCMKTS:ASPCF	OTCMKTS:AMAR	NASDAQ:MLNT
Price Information
Current Price	$0.67	$0.04	$0.04	$0.23	$0.50
52 Week Range	Hold	N/A	N/A	N/A	Hold
Analyst Ratings
Consensus Recommendation	Hold	N/A	N/A	N/A	Hold
Consensus Price Target	$14.00	N/A	N/A	N/A	$11.00
% Upside from Price Target	1,981.17% upside	N/A	N/A	N/A	2,100.00% upside
Trade Information
Market Cap	$4.99 million	$11.41 million	$9.80 million	$9.36 million	$6.88 million
Beta	N/A	2.52	1.95	0.16	4.16
Average Volume	13,693	1,652	5,643	3,128	713,628
Sales & Book Value
Annual Revenue	N/A	$7.38 million	$3.77 million	$80,000.00	$96.43 million
Price / Sales	N/A	1.31	2.60	117.05	0.07
Cashflow	N/A	N/A	N/A	N/A	N/A
Price / Cash	N/A	N/A	N/A	N/A	N/A
Book Value	$2.01 per share	N/A	N/A	$0.02 per share	$16.96 per share
Price / Book	N/A	∞	∞	11.56	0.03
Profitability
Net Income	$-27,120,000.00	$-18,790,000.00	$-16,130,000.00	$-1,340,000.00	$-157,190,000.00
EPS	($3.46)	N/A	N/A	N/A	($17.72)
Trailing P/E Ratio	N/A	0.00	N/A	N/A	N/A
Forward P/E Ratio	∞	∞	∞	∞	N/A
P/E Growth	N/A	N/A	N/A	N/A	N/A
Net Margins	N/A	-254.66%	-219.97%	-10,718.75%	-393.39%
Return on Equity (ROE)	-126.08%	-346.72%	N/A	-428.46%	-101.29%
Return on Assets (ROA)	-80.29%	-94.54%	-115.72%	-158.54%	-28.68%
Dividend
Annual Payout	N/A	N/A	N/A	N/A	N/A
Dividend Yield	N/A	N/A	N/A	N/A	N/A
Three-Year Dividend Growth	N/A	N/A	N/A	N/A	N/A
Payout Ratio	N/A	N/A	N/A	N/A	N/A
Years of Consecutive Dividend Growth	N/A	N/A	N/A	N/A	N/A
Debt
Debt-to-Equity Ratio	0.05%	0.64%	N/A	N/A	1.11%
Current Ratio	4.42%	1.35%	0.89%	0.90%	1.03%
Quick Ratio	4.42%	0.90%	0.71%	0.89%	0.72%
Ownership Information
Institutional Ownership Percentage	14.57%	0.02%	N/A	N/A	18.02%
Insider Ownership Percentage	N/A	N/A	N/A	N/A	60.30%
Miscellaneous
Employees	19	29	29	3	290
Shares Outstanding	7.42 million	258.61 million	261.23 million	40.52 million	13.75 million
Next Earnings Date	5/27/2020 (Estimated)	N/A	5/11/2020 (Estimated)	4/21/2020 (Estimated)	N/A
Optionable	Not Optionable	Not Optionable	Not Optionable	Not Optionable	Optionable

Comparison Ideas:

Your Ultimate Investing Toolkit

Just $1.00 for your first month.

Compare Stocks

Start Your Free Trial Today

Market Data and Calendars

Investing Education and Resources